SAVE THE DATE
TRANSLATING SCIENCE INTO SURVIVAL
SEPTEMBER 25-28, 2016, NEW YORK CITY

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to sponsor the International Cancer Immunotherapy Conference, which will take place in New York City on September 25-28, 2016. 

Entitled “Translating Science into Survival,” the meeting will feature more than 60 talks by acknowledged leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. 

Meeting Co-Chairs:

• James P. Allison, The University of Texas MD Anderson Cancer Center
• Philip D. Greenberg, Fred Hutchinson Cancer Research Center and University of Washington
• Christoph Huber, CIMT
• Guido Kroemer, Institut Gustave Roussy

Planning Committee Members:

• Wolf Fridman, Centre de Recherche des Cordeliers
• Axel Hoos, GlaxoSmithKline
• Elizabeth M. Jaffee, Johns Hopkins Kimmel Comprehensive Cancer Center
• Peter W.M. Johnson, Cancer Research UK Centre Southampton General Hospital
• Cornelis J.M. Melief, Leiden University Medical Center & ISA Pharmaceuticals
• Ira Mellman, Genentech, Inc.
• Ellen Puré, University of Pennsylvania
• Catherine Sautés-Fridman, Universite Paris-Descartes
• Drew Pardoll, Johns Hopkins Kimmel Comprehensive Cancer Center
• Robert D. Schreiber, Washington University School of Medicine
• Ozlem Tureci, Ganymed Pharmaceuticals
• E. John Wherry, University of Pennsylvania
• Theresa L. Whiteside, University of Pittsburgh Cancer Institute
• Laurence Zitvogel, Institut Gustave Roussy

REGISTRATION OPENING SOON
For more information, contact Lynne Harmer at lharmer@cancerresearch.org.